These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 37115542

  • 1. Treatment of US Children With Attention-Deficit/Hyperactivity Disorder in the Adolescent Brain Cognitive Development Study.
    Olfson M, Wall MM, Wang S, Laje G, Blanco C.
    JAMA Netw Open; 2023 Apr 03; 6(4):e2310999. PubMed ID: 37115542
    [Abstract] [Full Text] [Related]

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan 03; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 03; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 4. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
    Walls M, Allen CG, Cabral H, Kazis LE, Bair-Merritt M.
    Acad Pediatr; 2018 Apr 03; 18(3):256-265. PubMed ID: 29061327
    [Abstract] [Full Text] [Related]

  • 5. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J, Pliszka SR.
    J Pediatr; 2008 Mar 03; 152(3):394-9. PubMed ID: 18280848
    [Abstract] [Full Text] [Related]

  • 6. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F, Yilmaz I, Yulaf Y, Gokce S, Sabuncuoglu O.
    J Child Adolesc Psychopharmacol; 2017 Jun 03; 27(5):433-439. PubMed ID: 28332851
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV, Glatt SJ.
    J Clin Psychiatry; 2010 Jun 03; 71(6):754-63. PubMed ID: 20051220
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children.
    Shoval G, Visoki E, Moore TM, DiDomenico GE, Argabright ST, Huffnagle NJ, Alexander-Bloch AF, Waller R, Keele L, Benton TD, Gur RE, Barzilay R.
    JAMA Netw Open; 2021 Jun 01; 4(6):e2111342. PubMed ID: 34086035
    [Abstract] [Full Text] [Related]

  • 9. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
    Robison LM, Sclar DA, Skaer TL, Galin RS.
    Int Clin Psychopharmacol; 2004 Jan 01; 19(1):17-22. PubMed ID: 15101565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS, Genel M, Bezman RJ, Slanetz PJ.
    JAMA; 1998 Apr 08; 279(14):1100-7. PubMed ID: 9546570
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
    Babinski DE, Waxmonsky JG, Waschbusch DA, Humphery H, Pelham WE.
    J Child Adolesc Psychopharmacol; 2017 Apr 08; 27(3):250-257. PubMed ID: 27991835
    [Abstract] [Full Text] [Related]

  • 17. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
    Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.
    Pediatrics; 2004 Jul 08; 114(1):e1-8. PubMed ID: 15231966
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
    Brault MC, Lacourse É.
    Can J Psychiatry; 2012 Feb 08; 57(2):93-101. PubMed ID: 22340149
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.